The Evelyn F. McKnight Brain Institute at the University of Miami Miller School of Medicine brings together a cross-disciplinary team of translational scientists and clinicians to accelerate discoveries of age-related memory loss and cognitive impairment produced by various brain related disorders. It seeks to train the next generation of clinical translational investigators capable of translating scientific discoveries into clinical practice, and to advance brain health in communities.
https://mbi-umiami.org/wp-content/uploads/2021/06/23-October-2019-•-900-pm-The-Cable-Yacht-Club-1.png 1220 1300 Susan Fox-Rosellini https://mbi-umiami.org/wp-content/uploads/2021/09/mcknight-logo-with-space-below.png Susan Fox-Rosellini2021-06-10 18:21:582021-06-16 21:31:12The FDA approves Aduhelm (aducanumab) to treat patients with Alzheimer’s disease
FDA approves Aduhelm (aducanumab) using the accelerated approval pathway used for drugs treating serious or life-threatening illness that provide a meaningful therapeutic advantage over existing treatments. The drug is shown […]